Stock Events

Stock Events

Senseonics 

€4.24
425
-€0.02-0.47% Tuesday 19:55

Statistics

Day High
4.34
Day Low
4.08
52W High
12.82
52W Low
0.34
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q4 2025
Next
-0.58
-0.51
-0.44
-0.37
Expected EPS
-0.584998845
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 6L60.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Dexcom
DXCM
Mkt Cap23.67B
Dexcom produces continuous glucose monitoring systems for diabetes management, directly competing with Senseonics' Eversense CGM system.
Abbott Laboratories
ABT
Mkt Cap155.82B
Abbott Laboratories offers the FreeStyle Libre, a flash glucose monitoring system, competing in the glucose monitoring space.
Tandem Diabetes Care
TNDM
Mkt Cap1.33B
Tandem Diabetes Care manufactures insulin pumps and integrated diabetes management systems, competing in the broader diabetes management market.
Insulet
PODD
Mkt Cap12.12B
Insulet Corporation develops the Omnipod, an insulin management system, which competes with diabetes management solutions like Senseonics'.
Medtronic
MDT
Mkt Cap102.71B
Medtronic offers the Guardian Sensor 3 CGM and insulin pumps, providing integrated diabetes management solutions.
Mirum Pharmaceuticals
MIRM
Mkt Cap5.89B
Mirum Pharmaceuticals, though more focused on liver diseases, has interests in metabolic disorders, potentially overlapping with diabetes management.
Novo Nordisk
NVO
Mkt Cap194.57B
Novo Nordisk specializes in diabetes care with insulin and GLP-1 receptor agonists, indirectly competing in diabetes management.
Sanofi
SNY
Mkt Cap110.4B
Sanofi produces insulin and other diabetes medications, competing in the broader market for diabetes management.
Merck
MRK
Mkt Cap277.02B
Merck & Co., with its diabetes medication portfolio, including Glucophage, competes in the pharmaceutical management of diabetes.
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Bristol-Myers Squibb, through its metabolic disorders treatment portfolio, indirectly competes in the diabetes management space.

About

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Show more...
CEO
Dr. Timothy T. Goodnow Ph.D.
Employees
130
Country
United States
ISIN
US81727U3032

Listings

MU
DE
6L60.MU
STU
DE
6L60.STU
F
DE
6L60.F
XNAS
US
SENS

0 Comments

Share your thoughts

FAQ

What is Senseonics stock price today?▼
The current price of 6L60.STU is €4.24 EUR — it has decreased by -0.47% in the past 24 hours. Watch Senseonics stock price performance more closely on the chart.
What is Senseonics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Senseonics stocks are traded under the ticker 6L60.STU.
Is Senseonics stock price growing?▼
6L60.STU stock has fallen by -22.2% compared to the previous week, the month change is a -38.16% fall, over the last year Senseonics has showed a -63.19% decrease.
When is the next Senseonics earnings date?▼
Senseonics is going to release the next earnings report on May 07, 2026.
What were Senseonics earnings last quarter?▼
6L60.STU earnings for the last quarter are -0.39 EUR per share, whereas the estimation was -0.37 EUR resulting in a -5.68% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Senseonics have?▼
As of May 06, 2026, the company has 130 employees.
In which sector is Senseonics located?▼
Senseonics operates in the Other sector.
When did Senseonics complete a stock split?▼
The last stock split for Senseonics was on October 20, 2025 with a ratio of 1:20.
Where is Senseonics headquartered?▼
Senseonics is headquartered in Germantown, United States.